abstract |
The present invention is an anti-human cardiac troponin I recombinant antibody, relates to a novel isolated binding protein comprising a cTnI antigen binding domain, and studies the preparation and application of the binding protein. The binding protein has strong activity and high affinity with human cTnI protein, and can be widely used in the detection field of cTnI protein. |